"id:ID","uuid","name","description","label","instanceType","id","text"
"758","aaba7630-a6d2-41d8-ac94-f9162fc1b89b","OBJ1","Main objective","","OBJECTIVE","Objective_1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg])."
"759","60521b14-261d-44d8-8ca0-c301f0abdb72","OBJ2","Safety","","OBJECTIVE","Objective_2","To document the safety profile of the xanomeline TTS."
"760","74fa448b-3741-4f24-87c4-df787685c698","OBJ3","Behaviour","","OBJECTIVE","Objective_3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas."
